Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Canaccord Genuity

Read How Analysts Reacted To MongoDB Post Q1 Earnings Beat

Analysts appreciated MongoDB, Inc's (NASDAQ:MDB) Q1 beat but cut the price target to reflect macro headwinds. Needham analyst Mike Cikos maintained MongoDB with a Buy rating and lowered the price target from $362 to $310. The price target change reflected the declines in the broader stock market. Cikos acknowledged MongoDB's strong 1QF23 feat outperforming guidance and expectations.…

Adam & Co strengthened by parent's latest acquisition

Adam & Co strengthened by parent's latest acquisition

Deal sees the Edinburgh-based team double in size

Canaccord Genuity Maintains Buy Rating for Evolent Health: Here's What You Need To Know

Canaccord Genuity Maintains Buy Rating for Evolent Health: Here's What You Need To Know

Canaccord Genuity has decided to maintain its Buy rating of Evolent Health (NYSE:EVH) and raise its price target from $40.00 to $45.00. Shares of Evolent Health are trading down 2.43% over the last 24 hours, at $27.84 per share.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022

Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading period, Coupang closed at $11.99.

Canaccord Genuity Maintains Buy Rating for Alphabet: Here's What You Need To Know

Canaccord Genuity has decided to maintain its Buy rating of Alphabet (NASDAQ:GOOGL) and lower its price target from $3500.00 to $3300.00. Shares of Alphabet are trading down 3.63% over the last 24 hours, at $2286.75 per share.

Canaccord Genuity Maintains Buy Rating for Vapotherm, Lowers Price Target To $12

Canaccord Genuity has decided to maintain its Buy rating of Vapotherm (NYSE:VAPO) and lower its price target from $21.00 to $12.00. Shares of Vapotherm are trading down 1.52% over the last 24 hours, at $6.48 per share.

51 Biggest Movers From Yesterday

Gainers Advent Technologies Holdings, Inc. (NASDAQ: ADN) shares climbed 79.7% to close at $3.63 on Wednesday. Advent Technologies and Hyundai Motor Company entered into technology assessment, sales and development agreement.

inkl

Read news from The Economist, FT, and more,
with one subscription

40 Stocks Moving In Wednesday's Mid-Day Session

40 Stocks Moving In Wednesday's Mid-Day Session

Gainers Advent Technologies Holdings, Inc. (NASDAQ: ADN) shares jumped 77.7% to $3.5950. Advent Technologies and Hyundai Motor Company entered into technology assessment, sales and development agreement.

Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2022

Here's Why Canaccord Is Bullish On This Cryptocurrency Mining Company

Here's Why Canaccord Is Bullish On This Cryptocurrency Mining Company

Canaccord Genuity analyst Joseph Vafi initiated coverage of HIVE Blockchain Technologies Ltd (NASDAQ:HIVE) with a Buy rating and a $2.80 price target, suggesting an upside of 27%. Digital assets, especially Bitcoin and Ethereum, successfully exited another test of their resiliency in the face of recent market volatility. Vafi expects miners to benefit if bitcoin prices…

Read How Analysts Reacted To AeroVironment's Q3 Earnings Report

Read How Analysts Reacted To AeroVironment's Q3 Earnings Report

RBC Capital analyst Ken Herbert raised the price target on AeroVironment, Inc. (NASDAQ:AVAV) to $70 (4% downside) from $65 and maintained a Sector Perform rating on the shares after its Q3 earnings. The analyst states that while fundamentals appear to be improving for the company, the results also highlighted continued budget and supply chain risk,…

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Advanced Micro Devices

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play